BRAINSTORM CELL THERAPEUTICS INC. — Net Income by Fiscal Year
24 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/138fb863-92b7-43a2-9c90-8d396abc91d4/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-10.3M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-037927 |
| FY 2024 | $-11.6M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000545 |
| FY 2023 | $-17.2M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000385 |
| FY 2022 | $-24.3M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000426 |
| FY 2021 | $-24.5M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000554 |
| FY 2020 | $-31.8M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-011928 |
| FY 2019 | $-23.3M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-022244 |
| FY 2018 | $-13.9M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-017041 |
| FY 2017 | $-5.0M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-013470 |
| FY 2016 | $-5.0M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-017265 |
| FY 2015 | $-8.5M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-086932 |
| FY 2014 | $-9.2M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-018682 |
| FY 2013 | $-54.5M | 2000-09-23 – 2014-03-31 | evidence 0001144204-14-029919 |
| FY 2012 | $-48.6M | 2000-09-23 – 2013-03-31 | evidence 0001144204-13-027214 |
| FY 2011 | $-45.0M | 2000-09-23 – 2012-03-31 | evidence 0001144204-12-028107 |
| FY 2010 | $-2.4M | 2010-01-01 – 2010-12-31 | evidence 0001144204-11-051620 |
| FY 2009 | $-1.8M | 2009-01-01 – 2009-12-31 | evidence 0001144204-11-051620 |
| FY 2008 | $-3.5M | 2008-01-01 – 2008-12-31 | evidence 0001144204-11-051620 |
| FY 2007 | $-6.2M | 2007-01-01 – 2007-12-31 | evidence 0001144204-11-051620 |
| FY 2005 | $-3.3M | 2005-04-01 – 2006-03-31 | evidence 0001144204-11-051620 |
| FY 2004 | $-18.8M | 2004-04-01 – 2005-03-31 | evidence 0001144204-11-051620 |
| FY 2003 | $-73.0k | 2003-04-01 – 2004-03-31 | evidence 0001144204-11-051620 |
| FY 2002 | $-47.0k | 2002-04-01 – 2003-03-31 | evidence 0001144204-11-051620 |
| FY 2001 | $-26.0k | 2001-04-01 – 2002-03-31 | evidence 0001144204-11-051620 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BRAINSTORM CELL THERAPEUTICS INC. — all facts · Operating Income